Should the FDA approve Vertex’s new cystic fibrosis drug?

The scene at the FDA hearing was familiar. All theĀ  advisory committees have seen it play out again and again. Yesterday, it was the Pulmonary-Allergy Drug committee: The pharma doc with the convincing statement. The weeping patients. The drug likely to cost a couple thousand a month offering a slimĀ  benefit over an existing drugs. … Continue reading Should the FDA approve Vertex’s new cystic fibrosis drug?

Advertisements